Merck KGaA Quarterly Profit Beats Estimates; Forecast Raised

Updated on
  • Profit from healthcare unit climbed 16 percent in quarter
  • Sales and earnings in 2016 may be higher than earlier forecast

Merck KGaA reported second-quarter profit that beat analysts’ estimates as the prescription-drug division’s earnings climbed, prompting the German company to raise its forecast for the full year.

To continue reading this article you must be a Bloomberg Professional Service Subscriber.